UK markets close in 2 hours 53 minutes

JNJ Jan 2022 60.000 call

OPR - OPR Delayed price. Currency in USD
Add to watchlist
100.650.00 (0.00%)
As of 11:10AM EDT. Market open.
Full screen
Loading interactive chart…
  • Editor's pick
    Yahoo Finance Video

    'The threat of COVID is not gone," says Milwaukee medical director

    Dr. Ben Weston, Milwaukee COVID-19 Emergency Operations Center Medical Director, talks about the process of approving the COVID-19 vaccine for children and the global fight against COVID-19.

  • Editor's pick
    Yahoo Finance Video

    Novavax files first COVID-19 vaccine authorization in UK

    Novavax CEO Stanley Erck joins Yahoo Finance to discuss the company's filing for vaccine authorization in the UK, plans to seek approval from the FDA, and how supply chain disruption has affected the ramp-up of vaccine production.

  • Motley Fool

    What Investors Liked About Johnson & Johnson's Q3 Results

    Johnson & Johnson (NYSE: JNJ) recently reported its financial results for the third quarter of 2021. In this Motley Fool Live video recorded on Oct. 20, 2021, Motley Fool contributors Keith Speights and Brian Orelli talk about what investors especially liked about J&J's results. On Tuesday, yesterday, Johnson & Johnson announced its Q3 results.